Ordinary Adjustment | Solactive Global Health Services & Technology | April 2020
Solactive Global Health Services & Technology Americas:
In the ordinary rebalancing the following index composition will be implemented:
| ALEXION PHARMACEUTICALS INC |
| ALLERGAN PLC |
| ASCENDIS PHARMA A/S |
| BIO-RAD LABORATORIES INC |
| BIO-TECHNE CORP |
| BRISTOL-MYERS SQUIBB CO |
| CHINA BIOLOGIC PRODUCTS HOLD |
| DANAHER CORP |
| INCYTE CORP |
| JOHNSON & JOHNSON |
| MASIMO CORPORATION |
| MERCK & CO. INC. |
| PERKINELMER INC |
| PFIZER INC |
| TARO PHARMACEUTICAL INDUSTRIES ORD |
| WEST PHARMACEUTICAL SERVICES INC |
Solactive Global Health Services & Technology APAC:
In the ordinary rebalancing the following index composition will be implemented:
| ASAHI INTECC CO LTD |
| ASTELLAS PHARMA INC |
| CHINA MEDICAL SYSTEM HOLDINGS LTD |
| CHINA RESOURCES PHARMACEUTICAL |
| CHINA TRADITIONAL CHINESE MEDICINE HOLDINGS CO LTD |
| CHUGAI PHARMACEUTICAL CO LTD ORD |
| CSPC PHARMACEUTICAL GROUP LTD |
| DAIICHI SANKYO CO LTD ORD |
| GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO LTD |
| HANSOH PHARMACEUTICAL GROUP CO |
| HARTALEGA HOLDINGS |
| HISAMITSU PHARMACEUTICAL CO INC ORD |
| HOYA CORP ORD |
| IHH HEALTHCARE BHD |
| JAPAN LIFELINE CO LTD |
| JCR PHARMACEUTICALS CO LTD |
| KAKEN PHARMACEUTICAL CO LTD ORD |
| KOBAYASHI PHARMACEUTICAL LTD ORD |
| KYOWA KIRIN CO LTD |
| LUYE PHARMA GROUP LTD |
| MIRACA HOLDINGS (FUJIREBIO) ORD |
| NIHON KOHDEN CORP ORD |
| NIPRO (NISSHO) CORP ORD |
| ONO PHARMACEUTICAL CO LTD ORD |
| OTSUKA HOLDINGS CO LTD ORD |
| SANTEN PHARMACEUTICAL CO LTD ORD |
| SAWAI PHARMACEUTICAL CO LTD ORD |
| SHANDONG WEIGAO GROUP MEDICAL POLYMER CO LTD |
| SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD |
| SHANGHAI PHARMACEUTICALS HOLDING CO LTD-H |
| SHIONOGI & CO LTD ORD |
| SHIP HEALTHCARE HOLDINGS INC |
| SINO BIOPHARMACEUTICAL LTD ORD |
| SINOPHARM GROUP CO LTD |
| SSY GROUP LTD |
| ST SHINE OPTICAL CO LTD |
| SUMITOMO DAINIPPON PHARMA CO ORD |
| SUZUKEN CO LTD ORD |
| SYSMEX CORP ORD |
| TAIDOC TECHNOLOGY CORP |
| TAISHO PHARMACEUTICAL HOLDINGS CO LTD |
| TAKEDA PHARMACEUTICAL |
| TERUMO CORP |
| TOP GLOVE CORP BHD |
| TSUMURA & CO ORD |
| YUHAN CORP ORD |
Solactive Global Health Services & Technology EMEA:
In the ordinary rebalancing the following index composition will be implemented:
| ABCAM PLC |
| ALMIRALL SA |
| ARGENX SE |
| ASTRAZENECA PLC |
| BAYER AG |
| BIOMERIEUX |
| CHR HANSEN HOLDING AS |
| COLOPLAST AS CLASS B |
| CONVATEC GROUP PLC |
| DECHRA PHARMACEUTICALS PLC |
| DEMANT A/S |
| DIASORIN SPA |
| ESSILORLUXOTTICA |
| EUROFINS SCIENTIFIC SE |
| EVOTEC SE |
| FRESENIUS MEDICAL CARE AG & CO KGAA |
| GENMAB A/S |
| GLAXOSMITHKLINE PLC |
| GRIFOLS SA CLASS A |
| H LUNDBECK AS |
| HIKMA PHARMACEUTICALS PLC |
| KONINKLIJKE PHILIPS NV |
| KORIAN |
| LONZA GROUP AG |
| MERCK KGAA |
| NOVARTIS AG |
| NOVO NORDISK A/S |
| NOVOZYMES AS CLASS B |
| ORION OYJ CLASS B |
| RICHTER GEDEON VEGYESZETI GYAR NYILVANOSAN MUKODO RT. |
| ROCHE HOLDING AG |
| SANOFI SA |
| SARTORIUS AG PREF |
| SARTORIUS STEDIM BIOTECH |
| SIEGFRIED HOLDING AG-REG |
| SIEMENS HEALTHINEERS AG |
| SONOVA HOLDING AG |
| TECAN GROUP AG-REG |